Study Says Bayer's Trasylol Safe For Some Patients
The study was published Thursday by a team of British researchers in the United Kingdom-based medical journal The Lancet. It determined that Trasylol, also known as aprotinin, appeared to pose little risk for people undergoing on-pump bypass surgery, in which a machine keeps the patient's heart beating during the operation.
However, the risk of...
To view the full article, register now.